A detailed history of Dynamic Technology Lab Private LTD transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 6,226 shares of COLL stock, worth $194,188. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,226
Previous 6,947 10.38%
Holding current value
$194,188
Previous $224,000 7.14%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$31.4 - $39.07 $22,639 - $28,169
-721 Reduced 10.38%
6,226 $240,000
Q2 2024

Aug 14, 2024

BUY
$31.36 - $39.99 $217,857 - $277,810
6,947 New
6,947 $224,000
Q1 2023

May 12, 2023

BUY
$23.0 - $29.88 $661,457 - $859,318
28,759 New
28,759 $690,000
Q4 2021

Feb 14, 2022

SELL
$17.5 - $21.35 $253,557 - $309,340
-14,489 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$17.75 - $25.39 $257,179 - $367,875
14,489 New
14,489 $286,000
Q2 2019

Aug 14, 2019

SELL
$10.62 - $16.59 $526,900 - $823,096
-49,614 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$13.58 - $18.72 $673,758 - $928,774
49,614 New
49,614 $751,000
Q4 2018

Feb 13, 2019

SELL
$14.78 - $19.68 $512,200 - $682,010
-34,655 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$14.16 - $24.3 $490,714 - $842,116
34,655 New
34,655 $510,000
Q2 2018

Aug 14, 2018

SELL
$21.79 - $28.29 $182,491 - $236,928
-8,375 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$18.15 - $29.21 $60,040 - $96,626
-3,308 Reduced 28.31%
8,375 $214,000
Q4 2017

Feb 09, 2018

SELL
$9.3 - $19.14 $70,224 - $144,526
-7,551 Reduced 39.26%
11,683 $216,000
Q3 2017

Nov 08, 2017

BUY
$9.15 - $11.97 $175,991 - $230,230
19,234
19,234 $201,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.06B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.